Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 66.5 kDa. The protein migrates as 65-80 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Human ACHE, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
Measured by its ability to cleave Acetylthiocholine. The specific activity is >500 nmol/min/μg, as measured under the described conditions (QC tested).
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides comprehensive tools for neuroscience research, including neuroscience proteins, pre-formed fibrils (PFFs), neural antibodies, neural factors, and more—aiming to accelerate disease modeling, drug screening, and neural mechanism studies.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Galantamine Hydrobromide | GP-37267; R-113675 | Approved | AverTox, Nivalin, Reminyl, Razadyne, Reminyl XL | Mainland China | Alzheimer Disease | null | 1981-01-01 | Alzheimer Disease; Subarachnoid Hemorrhage; Dementia, Vascular; Frontotemporal Dementia; Fasting; Mental Disorders; Cognition Disorders; Lewy Body Disease; Cocaine-Related Disorders; Obesity; Nervous System Diseases; Dementia; Schizophrenia; AIDS Dementia Complex; Tobacco Use Disorder; Vascular Diseases; Autistic Disorder; Memory; Stroke; Bipolar Disorder; Insulin Resistance; Brain Diseases; Depressive Disorder, Major | Details | |
Neostigmine Bromide | Approved | Prostigmin | Mainland China | Flatulence; Urinary Retention; Myasthenia Gravis | Shanghai Sine Pharmaceutical Laboratories Co Ltd | 1995-01-01 | Myasthenia Gravis; Headache; Flatulence; Urinary Retention | Details | ||
Metrifonate | Bay-a-9826; Bayer-L-1359 | Approved | ProMem, Memobay, Bilarcil | Schistosomiasis | Details | |||||
Rivastigmine Tartrate | SDZ-212-713; SDZ 212713; SDZ-ENA-713; ONO-2540; ENA-713; ENA-713D | Approved | Novartis Pharma Ag | Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能 | EU | Parkinson Disease; Dementia; Alzheimer Disease | Novartis Europharm Ltd | 1998-05-11 | Substance-Related Disorders; Brain Injuries, Traumatic; Down Syndrome; Delirium; Neurobehavioral Manifestations; Alzheimer Disease; Dementia; Parkinson Disease; Cocaine-Related Disorders; Dementia, Vascular; Cognition Disorders; Anticholinergic Syndrome | Details |
Pyridostigmine Bromide | Ro-1-5130 | Approved | Valeant | Regonol, Mestinon | United States | Lambert-Eaton Myasthenic Syndrome | Bausch & Lomb (Singapore) Pvi Ltd | 1955-04-06 | Dyskinesias; Hypotension, Orthostatic; Fibromyalgia; Immunologic Deficiency Syndromes; Diabetes Mellitus; T-Lymphocytopenia, Idiopathic CD4-Positive; Fatigue Syndrome, Chronic; Colonic Diseases; Glycogen Storage Disease Type II; Parkinson Disease; Myasthenia Gravis; Poisoning; Coronavirus Disease 2019 (COVID-19); Lambert-Eaton Myasthenic Syndrome; Postural Orthostatic Tachycardia Syndrome; Heart Failure; Primary Dysautonomias; HIV Infections; Constipation | Details |
Dimebolin hydrochloride | BRN-0622478; PF-01913539; DMB-I | Approved | Bigespas Ltd | Dimebon | Russian Federation | Hypersensitivity; Rhinitis, Allergic; Dermatitis, Atopic | null | 1983-01-01 | Liver Failure; Huntington Disease; Rhinitis, Allergic; Alzheimer Disease; Dementia; Hypersensitivity; Dermatitis, Atopic | Details |
Donepezil Hydrochloride | DKF-310; BNAG; E-2020; E-2022; (±)-E-2020; IVL-3003; GB-5001; HZ007 | Approved | Eisai Co Ltd | Memac, Eranz, Memorit, Aricept Evess, Aricept, Aricept ODT, Aricept D, 安理申, ADLARITY | United States | Alzheimer Disease | Eisai Inc | 1996-11-25 | Cognitive Dysfunction; Radiation Injuries; Aphasia; Hearing Loss, Sensorineural; Fragile X Syndrome; Brain Neoplasms; Breast Neoplasms; Alzheimer Disease; Parkinson Disease; Alcoholism; Ischemic Stroke; Multiple Sclerosis; Dementia; Lewy Body Disease; Psychological Distress; Wounds and Injuries; Dementia, Vascular; Memory Disorders; Anorexia Nervosa; Cognition Disorders; Subarachnoid Hemorrhage; Attention Deficit Disorder with Hyperactivity; Migraine Disorders; Supranuclear Palsy, Progressive; Brain Ischemia; Down Syndrome; Depression; Autism Spectrum Disorder; Neurologic Manifestations; Osteoporosis; Diabetes Mellitus, Type 2; Visual Perception; Neoplasms; Sleep Wake Disorders; Fatigue; Anxiety Disorders; Delirium; Stroke; Neurotoxicity Syndromes; Central Nervous System Neoplasms; Autistic Disorder | Details |
Memantine Hydrochloride/Donepezil Hydrochloride | ADS-8704; D-797/D-324; CKD 355; BPS-034; BPDO-1603; MDX-8704 | Approved | Allergan Plc | Arimenda, Namzaric | United States | Alzheimer Disease | Abbvie Inc | 2014-12-23 | Alzheimer Disease | Details |
Huperzine A | SPN-817 | Approved | Chinese Academy Of Sciences, Mayo Clinic | 哈伯因, 双益平 | Mainland China | Alzheimer Disease | Henan Taloph Pharmaceutical Stock Co Ltd | 1994-01-01 | Brain Injuries, Traumatic; Seizures; Schizophrenia; Epilepsy; Alzheimer Disease; Learning Disabilities; Memory Disorders | Details |
Distigmine Bromide | BC-51 | Approved | Torii Pharmaceutical Co Ltd | Ubretid | Japan | Dysuria; Myasthenia Gravis | Torii Pharmaceutical Co Ltd | 1967-09-05 | Myasthenia Gravis; Esotropia; Glaucoma; Dysuria | Details |
Pralidoxime Chloride | 2-PAM-chloride | Approved | Baxter International Inc | Protopam chloride | United States | Poisoning | Baxter Healthcare Corp | 1964-03-11 | Poisoning | Details |
Pralidoxime Iodide | 2-PAMI; NSC-7760; 2-PAM Iodide | Approved | Japan | Poisoning | Sumitomo Dainippon | 1958-05-01 | Poisoning | Details | ||
Eserine Salicylate | Approved | Synapton SR, Xalieve, Antilirium | Delirium; Insulin Resistance; Psychotic Disorders; Pain, Postoperative; Glaucoma | Details | ||||||
Neostigmine methylsulfate | Approved | Bloxiverz, Intrastigmina, Juvastigmin, Stiglyn, Metastigmin | Japan | Myasthenia Gravis; Muscle Hypotonia | kyowayakuhin Co | 1936-10-01 | Myasthenia Gravis; Urinary Retention; Flatulence; Muscle Hypotonia; Neuromuscular Blockade | Details | ||
Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6 | Approved | 新乐敦 | Details | |||||||
Dextrose/Sodium Chloride/Potassium Chloride/Floxacillin sodium | Approved | Details | ||||||||
Dextrose/Sodium Chloride/Potassium Chloride/Anthralin | Approved | Details | ||||||||
Dextrose/Sodium Chloride/Potassium Chloride/Pralidoxime Chloride | Approved | Details | ||||||||
Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate | Approved | Poisoning | Details | |||||||
Naphazoline Hydrochloride/Neostigmine methylsulfate | Approved | Details | ||||||||
Dihydrogalanthamine Hydrobromide | Approved | Mainland China | Hemiplegia; Sciatica | null | 1982-01-01 | Hemiplegia; Sciatica | Details | |||
Securinine Nitrate | Approved | Poliomyelitis; Facial Paralysis | Details | |||||||
Rivastigmine transdermal patch (Luye Pharma) | LY-03013; LY-30410; RID-TDS | Approved | Acino International AG | Kingsmin, Rivirec | Mainland China | Alzheimer Disease | Luye Pharma Group Ltd | Alzheimer Disease; Parkinson Disease | Details | |
Glycopyrronium bromide/Neostigmine metilsulfate | Approved | Sintetica Gmbh | Novistig, Prevduo | Austria | Neuromuscular Blockade | Sintetica Gmbh | 2020-09-23 | Neuromuscular Blockade; Muscle Hypotonia | Details | |
Benzgalantamine | Alpha 1062; ALPHA-1062 Intranasal; GLN-1062; ALPHA-1062; ALPHA-1062IN | Approved | Galantos Pharma GmbH | Zunveyl | United States | Alzheimer Disease | Alpha Cognition Inc | 2024-07-26 | Brain Injuries, Traumatic; Cognitive Dysfunction; Alzheimer Disease | Details |
Atropine/Pralidoxime Chloride | Approved | Meridian Medical Technologies Inc | DUODOTE | United States | Poisoning; Organophosphate Poisoning | Meridian Medical Technologies LLC | 2002-01-17 | Drug-Related Side Effects and Adverse Reactions; Organophosphate Poisoning; Poisoning; Drug intoxications | Details | |
Acotiamide Hydrochloride Hydrate | Z-338; YM-443 | Approved | Zeria | Acofide | Japan | Dyspepsia | null | 2013-03-25 | Dyspepsia; Nausea | Details |
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Donepezil/Solifenacin | CPC-201 | Phase 3 Clinical | Cipla Inc, Allergan Plc | Urologic Diseases; Alzheimer Disease; Dementia | Details |
Botulinum toxin (CKD Bio) | CKDB-501B; CKDB-501-B; CKDB-501A; CKDB-501-A; CKDB-501 | Phase 3 Clinical | CKD Bio Corp | Nasolabial fold wrinkles; Spasm | Details |
BR-4001 | BNT-002; BR-4001 | Phase 3 Clinical | Boryung Pharmaceutical Co Ltd | Alzheimer Disease | Details |
Botulinum toxin E | EB-001; EB-001A; EB-001T; AGN-151586; BoNT/E; BoNTE | Phase 3 Clinical | Bonti Inc | Nasolabial fold wrinkles; Musculoskeletal Pain | Details |
Blarcamesine/Donepezil Hydrochloride | Phase 2 Clinical | Anavex Life Sciences Corp | Alzheimer Disease | Details | |
Ondansetron Hydrochloride/Pyridostigmine Bromide | GTB-004 | Phase 2 Clinical | Gt Biopharma Inc | Myasthenia Gravis | Details |
Pregnenolone | NBI-113 | Phase 2 Clinical | Neurocrine Biosciences Inc | Schizophrenia; Autism Spectrum Disorder; Menopausal symptoms; Depressive Disorder, Major; Depression; Anxiety; Autistic Disorder; Alcoholism; Stress Disorders, Post-Traumatic; Cocaine-Related Disorders; Low Back Pain | Details |
Fluoropezil | DC-20; DC-511020 | Phase 2 Clinical | Jiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Alzheimer Disease | Details |
Pyridostigmine | K-127 | Phase 2 Clinical | Kashiv BioSciences LLC | Musculoskeletal Diseases; Blepharoptosis; Urination Disorders; Fatigue Syndrome, Chronic | Details |
AT-004(Arctic Therapeutics) | AT-004(Arctic Therapeutics) | Phase 2 Clinical | Arctic Therapeutics International | Acne Vulgaris; Rosacea; Psoriasis; Dermatitis, Atopic | Details |
Huperizine-A (Biscayne Pharmaceuticals) | INS-001; BIS-001-ER; XEL-001-HG; XEL-001-HP; Hup-A; BIS-001 | Phase 2 Clinical | Harvard University | Seizures; Epilepsy, Complex Partial | Details |
EX-039 | EX-039 | Phase 2 Clinical | Excelsior Corp | Alzheimer Disease | Details |
donepezil (Vyant Bio) | VYNT-0126 | Phase 2 Clinical | Vyant Bio Inc | Rett Syndrome | Details |
YIV-906 | PHY-906; KD-018 | Phase 2 Clinical | Phytoceutica Inc | Liver Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Diarrhea; Hepatitis B; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details |
AD-35 | AD-35 | Phase 2 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Alzheimer Disease | Details |
Edrophonium Chloride | Phase 1 Clinical | Teligent | Myasthenia Gravis | Details | |
18F-flubatine | 18F-flubatine; norchloro-fluoroepibatidine-[18F]; flubatine-[18F]; Fluorine-18-flubatine | Phase 1 Clinical | Helmholtz-Zentrum Dresden-Rossendorf | Alzheimer Disease | Details |
Phenserine tartrate | DWJ301 | Phase 1 Clinical | Qr Pharma | Cognitive Dysfunction; Alzheimer Disease | Details |
Mecripyrine Hydrochloride | SCR-1693; Y-1A; Y-1 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, NeuroDawn Pharmaceutical Co Ltd | Brain Neoplasms; Alzheimer Disease | Details |
Methanesulfonyl fluoride | SNX-001 | Phase 1 Clinical | Senexta | Alzheimer Disease | Details |
Galantamine/Metformin | RJx-01 | Phase 1 Clinical | Rejuvenate Biomed NV | Muscular Atrophy | Details |
Donepezil transdermal patch(Dong-A ST) | DA-5207 | Phase 1 Clinical | Dong-A ST Co Ltd | Details | |
BR-4002 | BR-4002; BR-4002-1; BNT-003 | Phase 1 Clinical | Boryung Pharmaceutical Co Ltd | Alzheimer Disease | Details |
HHT-201 | HHT-201 | Phase 1 Clinical | Zhejiang Huahai Pharmaceutical Co Ltd | Hypertension; Alzheimer Disease | Details |
Rivastigmine (Lachesis Biosciences Pty) | Clinical | Nerve Degeneration | Details | ||
donepezil (Daewoong) | DWJ-1365 | Clinical | Daewoong Pharmaceutical Co Ltd | Alzheimer Disease | Details |
This web search service is supported by Google Inc.